India’s top drug regulator has admitted to widespread lapses in pharmaceutical manufacturing after the deaths of at least 20 children in Madhya Pradesh were linked to contaminated cough syrup.
The children died over the past month after consuming cough medicine containing toxic diethylene glycol in quantities nearly 500 times the permissible limit, officials said. The deaths were all linked to the Coldrif medicine, banned after a test confirmed the presence of the chemical.
